Table 1:
Cardiolipin molecular species differ across organisms and tissues. Abundance is expressed as percent of total cardiolipin.
| Source of Cardiolipin | Abundance (% total CL) | Molecular Species | Ref. |
|---|---|---|---|
| Human Heart | 80 ± 2.0 | (18:2)4 | (6) |
| 12 ± 2.0 | (18:1)–(18:2)3 | ||
| Human Lymphoblast | 35 ± 3.0 | (16:1)–(18:1)3 | (6) |
| 32.0 ± 3.0 | (18:2)4 | ||
| Bovine Heart | 47.7 ± 0.4 | (18:2)4 | (7) |
| 21.0 ± 1.8 | (18:2)3–(18:3) | ||
| 14.6 ± 0.6 | (18:1)–(18:2)3 | ||
| Mouse Heart | 41.6 ± 0.5 | (18:2)4 | (8) |
| 17.7 ± 0.4 | (18:2)3–(22:6) | ||
| 14.3 ± 0.3 | (18:1)–(18:2)3 | ||
| Rat Liver | 55 ± 1.0 | (18:2)4 | (4) |
| 39 ± 1.0 | (18:1)–(18:2)3 | ||
| Mouse Liver | 52.3 ± 0.6 | (18:2)4 | (8) |
| (4 mo. male) | 19.2 ± 0.2 | (18:1)–(18:2)3 | |
| Mouse Liver | 80.6 ± 0.8 | (18:2)4CL | (9) |
| (6 mo. male) | 11.3 ± 0.1 | (18:2)2–(18:1)–(20:3) | |
| Mouse Brain | 7.1 ± 0.1 | (18:1)4 | (10) |
| 6.3 ± 0.1 | (18:1)3–(20:4) | ||
| 6.2 ± 0.0 | (18:1)3–(22:6) | ||
| S. cerevisiae | 40.0 ± 3.0 | (16:1)–(18:1)3 | (6) |
| 31.1 ± 2.0 | (18:1)4 | ||
| 20.0 ± 2.0 | (16:1)2–(18:1)2 | ||
| Mouse Gastrocnemius Muscle | 26.3 ± 0.3 | (18:2)3–(18:1) | (9) |
| 23.7 ± 0.2 | (18:2)4 | ||
| 23.7 ± 0.2 | (18:2)–(20:3)3 |